Suntegrity Impeccable Skin Sunscreen Recall Issued Over Microbial Contamination Risk

A recall has been issued for nine lots of Suntegrity Impeccable Skin Sunscreen Foundation, after discovering that the products may be contaminated with mold, which may lead to the development of infections and adverse reactions.

Suntegrity Impeccable Skin Sunscreen Foundation is designed to help prevent sunburn and comes in 2 oz. orange tubes. In addition to serving as a sunscreen, the products are also marketed as a medium coverage foundation, which is made up of vitamins and peptides. However, the manufacturer now indicates that some tubes may contain more Aspergillus Sydowii mold than is allowed by federal law.

The U.S Food and Drug Administration (FDA) announced the Suntegrity sunscreen recall on June 11, warning that Aspergillus Sydowii may cause allergic skin reactions and related symptoms. Additionally, applying the contaminated sunscreen to open wounds or sunburned skin could result in a primary fungal skin infection.

If the recalled sunscreen contacts the eyes, it might cause eye infections. For immunocompromised individuals, a primary skin infection caused by Aspergillus species requires medical treatment.

"*" indicates required fields

Sunscreen-Cancer-Lawsuit-Lawyer
Sunscreen-Cancer-Lawsuit-Lawyer

"*" indicates required fields

Officials indicate that products from Lot 115BU have tested positive for a high mold count, leading the manufacturer to also recall additional lots, including: 107IV, 107NU, 109NU, 117BU, 113SA, 114SA, 106BR, and 101MO. The lot number can be found on the back side of the tube at the top, and each of the products were sold in 2 oz orange tubes. A full list of product names, shades and expiration dates can be found in the recall notice.

The recalled Suntegrity sunscreen products were sold online and in retail stores nationwide. All distributors, retailers, and website customers have been notified by email and are arranging for disposal of all recalled products. Anyone with a recalled product is advised to immediately stop using the sunscreen.

Consumers who purchased the recalled products through SuntegritySkincare.com or Amazon (sold by Suntegrity), can email ImpeccableSkinRecall@SuntegritySkincare.com with their order number, product lot number, and name for verification. They can also send a message to that email if they would rather exchange their recalled product for 5-in-1 Tinted Sunscreen and a free gift.

For store credit, consumers can contact the retailer. In both cases, they will be asked to provide proof of disposal with a photo of the tube’s back (showing the lot number) to process the recall.

Anyone who experiences any issues related to using this over-the-counter sunscreen product, should contact their physician or healthcare provider.

Adverse reactions or quality problems can be reported to the FDA’s MedWatch Adverse Event Reporting program.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall.
A federal judge has rejected a motion to dismiss claims involving wrongful death and negligence raised in lawsuits over social media addiction brought by families throughout the U.S.
A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker.